Recombinant multi-species Adrenomedullin/ADM protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Adrenomedullin/ADM protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a preprohormone which is cleaved to form two biologically active peptides, adrenomedullin and proadrenomedullin N-terminal 20 peptide. Adrenomedullin is a 52 aa peptide with several functions, including vasodilation, regulation of hormone secretion, promotion of angiogenesis, and antimicrobial activity. The antimicrobial activity is antibacterial, as the peptide has been shown to kill E. coli and S. aureus at low concentration. [provided by RefSeq, Aug 2014]
The Alternative Names of target: ADM,AM,AMPP,Adm,Adrenomedullin,Ap,H39316,PAMP,Pro-adrenomedullin,RATAP
Go
to Adrenomedullin/ADM products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T20629-Ag-1/ GM-Tg-hg-T20629-Ag-2 | Human Adrenomedullin/ADM protein | Human |
| GM-Tg-rg-T20629-Ag-1/ GM-Tg-rg-T20629-Ag-2 | Rat Adrenomedullin/ADM protein | Rat |
| GM-Tg-mg-T20629-Ag-1/ GM-Tg-mg-T20629-Ag-2 | Mouse Adrenomedullin/ADM protein | Mouse |
| GM-Tg-cynog-T20629-Ag-1/ GM-Tg-cynog-T20629-Ag-2 | Cynomolgus/Rhesus macaque Adrenomedullin/ADM protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T20629-Ag-1/ GM-Tg-felg-T20629-Ag-2 | Feline Adrenomedullin/ADM protein | Feline |
| GM-Tg-cang-T20629-Ag-1/ GM-Tg-cang-T20629-Ag-2 | Canine Adrenomedullin/ADM protein | Canine |
| GM-Tg-bovg-T20629-Ag-1/ GM-Tg-bovg-T20629-Ag-2 | Bovine Adrenomedullin/ADM protein | Bovine |
| GM-Tg-equg-T20629-Ag-1/ GM-Tg-equg-T20629-Ag-2 | Equine Adrenomedullin/ADM protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T20629-Ag-1/ GM-Tg-hg-T20629-Ag-2;
GM-Tg-rg-T20629-Ag-1/ GM-Tg-rg-T20629-Ag-2;
GM-Tg-mg-T20629-Ag-1/ GM-Tg-mg-T20629-Ag-2; GM-Tg-cynog-T20629-Ag-1/ GM-Tg-cynog-T20629-Ag-2; GM-Tg-felg-T20629-Ag-1/ GM-Tg-felg-T20629-Ag-2; GM-Tg-cang-T20629-Ag-1/ GM-Tg-cang-T20629-Ag-2; GM-Tg-bovg-T20629-Ag-1/ GM-Tg-bovg-T20629-Ag-2; GM-Tg-equg-T20629-Ag-1/ GM-Tg-equg-T20629-Ag-2 |
| Products Name | Adrenomedullin/ADM protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | Adrenomedullin/ADM |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Adrenomedullin/ADM protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.